Correlation Between CbdMD and Cyclo Therapeutics
Can any of the company-specific risk be diversified away by investing in both CbdMD and Cyclo Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CbdMD and Cyclo Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between cbdMD Inc and Cyclo Therapeutics, you can compare the effects of market volatilities on CbdMD and Cyclo Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CbdMD with a short position of Cyclo Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of CbdMD and Cyclo Therapeutics.
Diversification Opportunities for CbdMD and Cyclo Therapeutics
0.45 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between CbdMD and Cyclo is 0.45. Overlapping area represents the amount of risk that can be diversified away by holding cbdMD Inc and Cyclo Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cyclo Therapeutics and CbdMD is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on cbdMD Inc are associated (or correlated) with Cyclo Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cyclo Therapeutics has no effect on the direction of CbdMD i.e., CbdMD and Cyclo Therapeutics go up and down completely randomly.
Pair Corralation between CbdMD and Cyclo Therapeutics
Assuming the 90 days trading horizon cbdMD Inc is expected to under-perform the Cyclo Therapeutics. But the preferred stock apears to be less risky and, when comparing its historical volatility, cbdMD Inc is 7.98 times less risky than Cyclo Therapeutics. The preferred stock trades about -0.01 of its potential returns per unit of risk. The Cyclo Therapeutics is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest 14.00 in Cyclo Therapeutics on August 27, 2024 and sell it today you would earn a total of 0.00 from holding Cyclo Therapeutics or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 76.19% |
Values | Daily Returns |
cbdMD Inc vs. Cyclo Therapeutics
Performance |
Timeline |
cbdMD Inc |
Cyclo Therapeutics |
CbdMD and Cyclo Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with CbdMD and Cyclo Therapeutics
The main advantage of trading using opposite CbdMD and Cyclo Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CbdMD position performs unexpectedly, Cyclo Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cyclo Therapeutics will offset losses from the drop in Cyclo Therapeutics' long position.The idea behind cbdMD Inc and Cyclo Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.Cyclo Therapeutics vs. Eliem Therapeutics | Cyclo Therapeutics vs. HCW Biologics | Cyclo Therapeutics vs. Scpharmaceuticals | Cyclo Therapeutics vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Other Complementary Tools
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |